Abstract
186Re and 188Re, two strong beta- and weak gamma-emitters having short half-lives, are intensely studied as promising radionuclides for radiotherapy. Their use for biomolecule labeling is mainly due to their similar behavior with 99mTc. This paper presents the irradiation operations in a 14 MW Triga SSR Reactor, the chemical processing for obtaining a perrhenate solution of high activity and the final characterization of the products.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
